share_log

Aslan Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(7.8%),Tang Capital Management, LLC(7.8%), etc.

Aslan Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(7.8%),Tang Capital Management, LLC(7.8%)等

美股sec公告 ·  2023/02/14 16:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息